A clinical study was conducted to evaluate the efficacy and safety of percutaneous coronary excimer laser angioplasty in 60 patients with coronary artery disease. Forty-nine patients had stable exertional angina, and 11 patients had unstable angina despite medical therapy. A novel 1.4-mm diameter catheter with 20 quartz fibers of 100-gm diameter each arranged concentrically around a central lumen suitable for a 0.014-in. flexible guide wire was coupled to an excimer laser. A commercial excimer laser emitting energy at a wavelength of 308 nm with a pulse duration of 60 nsec was used. The laser was operated at 20 Hz. Mean energy transmission was 30±+5 mJ/mm2. In five of the 60 patients, laser angioplasty was not attempted. In 23 patients with laser ablation alone, percent stenosis decreased from 76±14% before to 27±17% after ablation and was 34±15% at the early follow-up angiogram. In 32 patients, additional balloon angioplasty was performed because of vessel closure after laser ablation in 11 and an insufficient qualitative result in 21 patients. Of the 11 patients with unstable angina, one patient died due to vessel closure 3 hours after intervention, and two patients developed a myocardial infarction. In 22 of 47 patients with late follow-up angiography, restenosis within the 6-month follow-up period occurred. Rate of restenosis was higher in patients treated with laser ablation and balloon angioplasty (16 of 28) than in patients treated with laser ablation alone (six of 19). These results suggest that coronary excimer laser angioplasty for ablation of obstructive lesions is feasible and safe in patients with stable angina. However, development of new catheter systems is necessary for an improved success rate. (Circulation 1990;81:1849-1859 In 1977, Andreas Gruntzig introduced the technique of transluminal balloon dilatation of coronary artery stenoses for treatment of atherosclerotic obstructions.' Conventional balloon angioplasty has shown impressive clinical results but is limited by a restenosis rate that approaches 30-40%.2,3 Laser technology was suggested as an alternative approach for treatment of coronary artery disease. However, the technique of laser recanalization or laser angioplasty so far has been limited by a 20-30% incidence of vessel perforation in experimental4'5 and clinical6'7 studies. Among the considerable variety of lasers, the excimer laser has been suggested to represent a From
with laser ablation alone, percent stenosis decreased from 76±14% before to 27±17% after ablation and was 34±15% at the early follow-up angiogram. In 32 patients, additional balloon angioplasty was performed because of vessel closure after laser ablation in 11 and an insufficient qualitative result in 21 patients. Of the 11 patients with unstable angina, one patient died due to vessel closure 3 hours after intervention, and two patients developed a myocardial infarction. In 22 of 47 patients with late follow-up angiography, restenosis within the 6-month follow-up period occurred. Rate of restenosis was higher in patients treated with laser ablation and balloon angioplasty (16 of 28) than in patients treated with laser ablation alone (six of 19). These results suggest that coronary excimer laser angioplasty for ablation of obstructive lesions is feasible and safe in patients with stable angina. However, development of new catheter systems is necessary for an improved success rate. (Circulation 1990; 81:1849 -1859 In 1977, Andreas Gruntzig introduced the technique of transluminal balloon dilatation of coronary artery stenoses for treatment of atherosclerotic obstructions.' Conventional balloon angioplasty has shown impressive clinical results but is limited by a restenosis rate that approaches 30-40%.2,3 Laser technology was suggested as an alternative approach for treatment of coronary artery disease. However, the technique of laser recanalization or laser angioplasty so far has been limited by a 20-30% incidence of vessel perforation in experimental4'5 and clinical6'7 studies. Among the considerable variety of lasers, the excimer laser has been suggested to represent a viable alternative therapy. 8 Experimental and clinical studies in smaller peripheral vessels indicate that the emitted excimer laser light cuts through tissue while creating only minimal thermal injury.9,10 However, See p 2018 clinical application of excimer laser energy on coronary atherosclerotic lesions has been limited by inadequate delivery systems. The energy generated by an excimer laser must be coupled in fiberoptic fibers that should allow transmission of energy for effective ablation of tissue.
Recently, a catheter system has been developed that has proved to be safe and effective for intracoronary ablation of obstructive lesions in the first 30 patients of this series with coronary artery disease. " The protocol of excimer laser angioplasty was approved by the Institutional Review Board Committee at the University of Tuebingen. Informed consent was obtained from each patient before the intervention.
Study Protocol
The patients were prepared for excimer laser angioplasty with standard angioplasty techniques via the percutaneous femoral approach. All patients were maintained on long-term treatment with acetylsalicylic acid (250 mg/day). After a heparin bolus (10.00 units given intra-arterially), the lesion site was visualized, and intracoronary nitroglycerin (100 ,Lg) was administered. With a 9F large-lumen guiding catheter placed in the ostium of the target vessel, the 0.014-in.-diameter flexible guide wire was advanced across the lesion into the distal vessel, and its location was confirmed angiographically. In nine patients with total occlusion of the target vessel, recanalization was achieved by guide wire alone. The laser catheter was then advanced over the guide wire through the proximal vessel up to the lesion. Advancement of the laser catheter through the lesion was attempted during 10-30 seconds of laser energy delivery, depending on the length of the lesion. Advancement of the laser catheter was performed by applying only moderate pressure on the device. Irradiation of the lesion was also performed during slow withdrawal of the catheter. This procedure was repeated at least twice, and after each irradiation cycle, control angiography was performed. The procedure was terminated if no visible change in luminal diameter in comparison with that obtained during the previous cycle was observed. Angiography of the target vessel was repeated after a control period of at least 10 minutes to confirm lesion morphology after intervention. The decision to perform additional balloon angioplasty was based on the qualitative judgment of the lesion severity after laser irradiation. In patients with an unsatisfactory result after laser angioplasty, subsequent conventional balloon angioplasty was performed. Additional balloon angioplasty was also performed when vessel occlusion during or immediately after laser treatment occurred. All patients were monitored for at least 24 hours after intervention in the coronary care unit. Blood samples for enzyme levels of creatine kinase and the MB isoenzyme of creatine kinase were taken every 3 hours, and an electrocardiogram was obtained every 6 hours. Twenty-four to 36 hours after intervention, early follow-up angiography was performed in 50 patients. Forty-seven patients underwent follow-up angiography 150±49 days (range, 30-212 days) after intervention. Five patients refused the invasive late follow-up study.
Coronary Arteriographic Analysis
Qualitative analysis of coronary morphology was obtained by a blinded review of the angiograms by a consensus of three experienced observers. All films were also analyzed by quantitative arteriographic techniques. Quantitative analysis of the lesions before and after each irradiation cycle and at the early and late follow-up angiogram was performed with identical angiographic projections by means of a computer-based coronary angiographic analysis system.12 It has been shown that this system allows accurate and more objective measurements of stenosis severity. 13 The minimal stenosis diameter and percent stenosis were calculated. Success of laser angioplasty and balloon dilatation was defined as a reduction of lesion severity of more than 50% from before to after intervention.
The early and late follow-up angiograms of the target vessel were performed by standardized acquisition and analysis. The angular settings of the radiograph gantry and the various height levels were readjusted according to the values previously documented to correspond as much as possible to the projections used during the previous angiographies. To minimize possible blurring effects, only enddiastolic cine frames were analyzed.
Two definitions of restenosis were applied: 1) loss of at least a 50% gain in luminal diameter achieved at angioplasty (National Heart, Lung, and Blood Institute IV) and 2) a decrease in minimal luminal diameter of greater than or equal to 0.72 mm with respect to the postintervention situation.14
Results
In five of 60 patients, excimer laser angioplasty could not be performed because of vessel tortuosities proximal to the lesion and at the site of the plaque. It was not possible to place the catheter in an axial position within the vessel, and thus laser irradiation was not initiated to avoid vessel injury.
In 55 patients in whom laser angioplasty was possible, percent stenosis decreased from 81±47% (mean+ SD) before to 37±17% after laser treatment. The minimal luminal diameter increased from 0.45±0.36 before to 1.66±0.47 mm after laser ablation. In 23 of these 55 (42%) patients, no additional balloon angioplasty was performed (Figure 1 ). Percent stenosis decreased from 76±14% before to 27±17% after laser angioplasty and was 34±15% at the 24-hour control angiogram. The minimal luminal diameter increased from 0.53±0.34 mm before to 1.78±0.45 mm after laser angioplasty and was 1.77±0.6 mm 24 hours later. In 32 patients, percent stenosis decreased from 85±14% before to 44±14% after coronary excimer laser treatment, and conventional balloon angioplasty was performed (Figure 2 ), resulting in a residual percent stenosis of 24±15%. At the early follow-up angiography in 27 patients, percent stenosis had increased to 32±24% ( One of the nine patients who had successful balloon dilatation after vessel occlusion and laser angioplasty developed an anterior ST-T segment elevation, hypotension, and ventricular tachycardia suggestive of abrupt vessel closure 3 hours after intervention and could not be resuscitated (patient 3). Percutaneous transluminal coronary excimer laser angioplasty was uncomplicated in 44 of 55 patients. In all 44 patients, no significant electrocardiographic changes or rise in creatine kinase and MB isoenzyme creatine kinase levels indicative of distal embolization occurred within the control period. All of these patients tolerated the intervention very well without symptoms such as chest pain or burning sensations. There was no evidence of vessel perforation or extravasation of contrast medium in any patient.
In the subgroup of 11 patients with unstable angina, laser irradiation of the ischemia-related lesion could be performed in 10 and was successful in only two patients (patients 10 and 55). In the remaining eight patients, additional balloon angioplasty was necessary due to acute vessel closure in four patients (patients 3, 20, 41, and 54) and to an insufficient result in the residual four patients (patients 21, 26, 35, and 54). In five of these eight patients, additional balloon angioplasty was successful, and the following clinical course unremarkable.
However, one patient of this group (patient 3) died soon after the intervention, and two patients experienced a myocardial infarction. Thus, all three serious complications occurred in patients with unstable angina ( Table 2) .
The clinical course in 44 patients was uneventful. Early follow-up angiography demonstrated a patent vessel in all patients. The severity of the residual lesion was comparable to the angiographic result immediately after intervention. A stress test performed before hospital discharge was unremarkable in all but two patients, who had three-vessel disease and exertional angina at maximum exercise (patients 22 and 33).
In the last patient of this series (patient 60), we encountered a technical problem with the catheter tip; the gold marker at the tip separated from the laser catheter during slow withdrawal after initially successful lesion ablation and perforated the vessel wall. Subsequent spasm and vessel occlusion was managed by immediate balloon dilatation, and patency of the vessel was achieved and still present at the early follow-up angiography. Probably as a result of the very thin gold marker (100 gtm), neither pericardial effusion nor recurrent ischemia occurred during follow-up. Initial energy transmission of the laser catheter was found to be 30-5 mJ/mm2. Energy transmission was above the ablative threshold in all catheters before intervention. Mean irradiation time was 123+65 seconds. Energy fluence after treatment was found to be 16±10 mJ/mm2. The decrease of transmitted energy did not seem to be dependent on lesion length and was independent on the initial energy transmission.
Additionally, the angiographic success and incidence of complications was not dependent on the energy threshold of the catheter before or after intervention.
During the 6-month follow-up period, no patient died. Myocardial infarction did not occur within the control period. The individual data of the 47 patients in whom late follow-up angiography was performed are given in Table 3 and summarized in A previous myocardial infarction in the perfusion area of the target vessel was not associated with a higher incidence of restenosis (Table 3) . Discussion The need for alternative therapeutic approaches in the management of patients with coronary artery disease led to the development and evaluation of excimer laser angioplasty. Excimer laser angioplasty proved to be safe and effective for ablation of atherosClerotic lesions in the majority of all patients. However, additional balloon angioplasty was needed in 58% of the population. Because The overall restenosis rate in the total group, 42%, is comparable with that of late follow-up studies after PTCA.23'14 The incidence of restenosis, however, was increased in patients in whom laser ablation of the lesion was incomplete or complicated and additional balloon angioplasty was necessary. Based on this limited experience, we feel that the combination of both methods for treatment of obstructive lesions may reduce long-term success rates. However, evidence of restenosis was also present in patients treated with only laser ablation. As previously alluded to, acute success of laser ablation was limited due to the prototypical device. Thus, whether the restenosis rate after laser ablation alone can be improved with modified catheters in comparison with balloon angioplasty has to be determined in larger patient populations.
Clinical Implications
The foregoing data in this pilot study led us to conclude that 1) coronary excimer laser angioplasty for ablation of obstructive lesions is feasible and safe in patients with stable angina pectoris, 2) development of improved catheter devices is mandatory, 3) treatment of vessels with severe proximal tortuosities should be avoided until catheter flexibility is improved, and 4) the combination of excimer laser ablation and balloon angioplasty might increase incidence of restenosis. Selection of patients suitable for coronary excimer laser angioplasty is crucial, at least with the currently available devices. We feel, however, that the results of this study are encouraging and justify further evaluation by controlled trials. 
